ViraTherapeutics Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
33
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$243M
- Investors
-
1
ViraTherapeutics General Information
Description
Developer of a next-generation oncolytic viral therapy platform created for the treatment of cancer. The company develops highly potent anti-cancer therapeutics based on oncolytic viruses that efficiently destroy cancer cells while leaving normal tissues unharmed, enabling research scientists to develop oncolytic cancer vaccines based on a chimeric virus derived from the vesicular stomatitis virus.
Contact Information
Website
www.viratherapeutics.com(Operating Subsidiary)
Corporate Office
- Bundesstraße 27
- Rum, 6063
- Austria
Corporate Office
- Bundesstraße 27
- Rum, 6063
- Austria
ViraTherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 13-Sep-2018 | $243M | Completed | Generating Revenue | ||
| 7. Early Stage VC (Series B) | 28-Oct-2016 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series A) | 24-Jun-2015 | Completed | Startup | |||
| 5. Grant | 01-Dec-2014 | Completed | Startup | |||
| 4. Grant | 01-Jul-2013 | Completed | Startup | |||
| 3. Angel (individual) | 01-Apr-2013 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Apr-2013 | Completed | Startup |
ViraTherapeutics Comparisons
Industry
Financing
Details
ViraTherapeutics Competitors (100)
One of ViraTherapeutics’s 100 competitors is Replimune, a Formerly VC-backed company based in Woburn, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Replimune | Formerly VC-backed | Woburn, MA | ||||
| Dendreon | Formerly VC-backed | Seal Beach, CA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Instil Bio | Formerly VC-backed | Dallas, TX |
ViraTherapeutics Patents
ViraTherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230183650-A1 | Vsv rescue | Active | 09-Jul-2021 | ||
| US-20220088162-A1 | Heterologous prime boost vaccine | Inactive | 14-Sep-2020 | ||
| US-20250312428-A1 | Heterologous prime boost vaccine | Pending | 14-Sep-2020 | ||
| US-20220010286-A1 | Process for producing a purified rhabdovirus from cell culture | Inactive | 10-Jul-2020 | ||
| US-12171795-B2 | Recombinant rhabdovirus encoding for a cd80 extracellular domain fc-fusion protein | Active | 03-Jun-2020 | A61K35/766 |
ViraTherapeutics Signals
ViraTherapeutics Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AplusB | Accelerator/Incubator | |||
| Austria Wirtschaftsservice | Venture Capital | Minority | ||
| Boehringer Ingelheim Venture Fund | Corporate Venture Capital | Minority | ||
| EMBL Ventures | Venture Capital | Minority | ||
| EMPL Fahrzeugwerk | Corporation | Minority |
ViraTherapeutics FAQs
-
When was ViraTherapeutics founded?
ViraTherapeutics was founded in 2013.
-
Where is ViraTherapeutics headquartered?
ViraTherapeutics is headquartered in Rum, Austria.
-
What is the size of ViraTherapeutics?
ViraTherapeutics has 33 total employees.
-
What industry is ViraTherapeutics in?
ViraTherapeutics’s primary industry is Drug Discovery.
-
Is ViraTherapeutics a private or public company?
ViraTherapeutics is a Private company.
-
What is the current valuation of ViraTherapeutics?
The current valuation of ViraTherapeutics is .
-
What is ViraTherapeutics’s current revenue?
The current revenue for ViraTherapeutics is .
-
How much funding has ViraTherapeutics raised over time?
ViraTherapeutics has raised $8.55M.
-
Who are ViraTherapeutics’s investors?
AplusB, Austria Wirtschaftsservice, Boehringer Ingelheim Venture Fund, EMBL Ventures, and EMPL Fahrzeugwerk are 5 of 9 investors who have invested in ViraTherapeutics.
-
Who are ViraTherapeutics’s competitors?
Replimune, Dendreon, Inovio Pharmaceuticals, Carisma Therapeutics, and Instil Bio are some of the 100 competitors of ViraTherapeutics.
-
When was ViraTherapeutics acquired?
ViraTherapeutics was acquired on 13-Sep-2018.
-
Who acquired ViraTherapeutics?
ViraTherapeutics was acquired by Boehringer Ingelheim.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process